RSS
17 May 2021

Blueprint Medicines Appoints Percy Carter, MBA, Ph.D., as Chief Scientific Officer

Author: admintech | Filed under: Press Release

CAMBRIDGE, Mass., May 17, 2021 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the appointment of Percy Carter, MBA, Ph.D., as Chief Scientific Officer, effective May 19, 2021. In this role, Dr. Carter will oversee all of the company’s research and…

This entry was posted on Monday, May 17th, 2021 at 7:06 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»